FaceHeart
PrivateLast Round
Series A
Jul 1, 2022
Est. Valuation
$16.2M
Total Funding Raised
$9.42M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
FaceHeart operates in Healthcare & Life Sciences and is based in Taipei City. Its latest recorded funding round was a Series A round in July 2022.
FaceHeart is a health technology company that provides an AI-driven, video-based software development kit for contactless vital sign measurement.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Computer Vision, Telemedicine, InsurTech
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FaceHeart Comparables
Compare FaceHeart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NuraLogix | 91% | |
| PanopticAI | 89% | |
| Lifelight | 89% |
For institutional investors. Book with your work email.
FaceHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2022 | ||||
| Pre Seed | Jun 10, 2019 | ||||
| Grant | Aug 10, 2018 |
For institutional investors. Book with your work email.
FaceHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A |
| National Science and Technology Council | Grant |
| Taiwan Tech Arena | Grant |
| Abico Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 90% MoM, reaching 20K.
- Jun 19, 2026
Monthly visitors grew 97% MoM, reaching 10K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
FaceHeart Corp. presents CardioMirror at the Taiwan Innotech Expo in Taiwan in Sep '26.
- partners_withSep 9, 2026
FaceHeart Corp. collaborates with Vghtpe on clinical trials as part of work with medical centers that covers nearly 30 trials, more than 36,000 subjects, and over 300 million image data points.
- partners_withSep 9, 2026
FaceHeart Corp. collaborates with Chang Gung Memorial Hospital as part of its work with medical centers on nearly 30 clinical trials, accumulating data from more than 36,000 subjects and over 300 million image data points.
For institutional investors. Book with your work email.
FaceHeart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FaceHeart's valuation, stock price, and market status.
Is FaceHeart a public or private company?
FaceHeart is a private company.
What is the current stock price of FaceHeart?
FaceHeart is a private company, so its shares have no public market price. Caplight tracks FaceHeart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FaceHeart worth (valuation)?
FaceHeart's valuation is estimated at $16.2M based on funding round data.
Can I buy FaceHeart stock?
FaceHeart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FaceHeart's last funding round?
FaceHeart's most recent funding round was Series A on July 1, 2022.
Who are the main investors in FaceHeart?
Key investors in FaceHeart include Taiwania Capital.
Will FaceHeart IPO soon?
No public IPO plans have been announced for FaceHeart.
How can I track FaceHeart secondary market activity?
Caplight tracks bids, offers, and trades in FaceHeart's shares on secondary markets.